Roche Hldg's Genentech broke ground on its newest U.S. manufacturing site in Holly Springs, North Carolina
- This significant development marks the establishment of Genentech's first manufacturing facility on the East Coast. The 700,000-square-foot facility is strategically designed to support production of the company's future portfolio of metabolic medicines, including next-generation treatments for obesity. The event was attended by federal, state and local officials, including U.S. Rep. Deborah Ross, North Carolina Gov. Josh Stein, State Sec. of Commerce Lee Lilley, State Sens. Sydney Batch and Lisa Grafstein, State Rep. Erin Paré, Wake County Commissioner Cheryl Stallings and Holly Springs Mayor Sean Mayefskie.
- The $700 million project is part of Genentech and Roche's $50 billion investment in U.S. manufacturing, infrastructure and R&D.
- The facility will create more than 1,900 jobs and support the production of next-generation metabolic medicines, including treatments for obesity.
- U.S. Rep. Deborah Ross, Gov. Josh Stein and other local leaders attended the groundbreaking event.